Schizophrenia Relapse Prevention Research Study

Location:
Maitland
Indication:
Schizophrenia
Age Range:
18 to 55

Relapses are a concern among all people with schizophrenia.

If you or someone you know is being treated for schizophrenia, learn about this study of an investigational medication that is taken with your current treatment to potentially help prevent relapses from occurring.

To participate, you or someone you care about must:

• Be 18 to 55 years of age
• Have been diagnosed with schizophrenia for at least 1 year
• Be currently taking medication for schizophrenia
• Meet additional study criteria

All study-related visits, tests, and drugs will be provided to you at no cost. In addition, you may be reimbursed for study-related time and travel.
To learn more about the study and to see if you may qualify, please call Meridien Research at 407-644-1165 or complete the form below.